Skip to main content
logo
Proteomics International Laboratories Ltd (ASX:PIQ)
Australia flag Australia · Delayed Price · Currency is AUD
0.1175
+0.0125 (11.90%)
Oct 29, 2026, 2:21 PM AEDT

ASX:PIQ Revenue

In the fiscal year ending June 30, 2026, Proteomics International Laboratories had annual revenue of 3.37M AUD with 1.75% growth. Proteomics International Laboratories had revenue of 2.64M in the half year ending June 30, 2026, a decrease of -0.39%. That makes Proteomics International Laboratories the 42,029th largest company in the world by revenue and 857th in Australia.

Revenue
3.37M
Revenue Growth
+1.75%
P/S Ratio
5.77
Revenue / Employee
n/a
Employees
n/a
Market Cap
19.43M

Revenue Chart

Chart

Revenue by Geography

Chart
  • Australia and NZ 229.69K 82.6%
  • India 30.94K 11.1%
  • USA (And Territories) 17.38K 6.3%
Fiscal year ended Jun 30, 2026 See the full ASX:PIQ breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20263.37M57.85K1.75%
Jun 30, 20253.31M43.87K1.34%
Jun 30, 20243.27M87.53K2.75%
Jun 30, 20233.18M-249.17K-7.26%
Jun 30, 20223.43M694.47K25.38%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
EZZ Life Science Holdings46.28M
Botanix Pharmaceuticals33.80M
Radiopharm Theranostics12.87M
Argenica Therapeutics5.48M
Imugene2.09M
Noxopharm1.43M
ReNerve510.36K
Algorae Pharmaceuticals77.67K
Revenue Rankings

Proteomics International Laboratories News

More News